IL1B and acute monocytic leukemia: Because no cytotoxicity was observed upon treating human acute monocytic leukemia cell line (THP-1) cells with βγ-CAT at concentrations less than 20 nM (Supplementary Fig. 1a), 5 nM βγ-CAT was used for the subsequent IL-1β release assay.